Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 11 01 2023
accepted: 20 03 2023
pmc-release: 01 09 2024
medline: 24 8 2023
pubmed: 28 3 2023
entrez: 27 3 2023
Statut: ppublish

Résumé

Guidelines recommend that all hospitalized patients with cirrhosis and ascites receive an early (<24 h from admission) paracentesis. However, national data are not available regarding compliance with and the consequences of this quality metric. We used the national Veterans Administration Corporate Data Warehouse and validated International Classification of Disease codes to evaluate the rate and subsequent outcomes of early, late, and no paracentesis for patients with cirrhosis and ascites during their first inpatient admission between 2016 and 2019. Of 10,237 patients admitted with a diagnosis of cirrhosis with ascites, 14.3% received an early paracentesis, 7.3% received a late paracentesis, and 78.4% never received a paracentesis. In multivariable modeling, compared with an early paracentesis: both late paracentesis and no-paracentesis were significantly associated with increased odds of acute kidney injury (AKI) development [OR: 2.16 (95% CI, 1.59-2.94) and 1.34 (1.09-1.66), respectively]; intensive care unit (ICU) transfer [OR: 2.43 (1.71-3.47) and 2.01 (1.53-2.69), respectively] and inpatient death [OR: 1.54 (1.03-2.29) and 1.42 (1.05-1.93), respectively]. Nationally, only 14.3% of admitted veterans with cirrhosis and ascites received the American Association for the Study of Liver Diseases (AASLD) guideline-recommended diagnostic paracentesis within 24 hours of admission. Failure to complete early paracentesis was associated with higher odds of AKI, ICU transfer, and inpatient mortality. Universal and site-specific barriers to this quality metric should be evaluated and addressed to improve patient outcomes.

Identifiants

pubmed: 36971257
doi: 10.1097/LVT.0000000000000137
pii: 01445473-990000000-00130
pmc: PMC10523869
mid: NIHMS1886089
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

919-927

Subventions

Organisme : CSRD VA
ID : I01 CX001076
Pays : United States
Organisme : CSRD VA
ID : I01 CX002472
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American Association for the Study of Liver Diseases.

Références

J Hepatol. 2021 Feb;74(2):330-339
pubmed: 32781201
N Engl J Med. 2021 Nov 4;385(19):1737-1749
pubmed: 34554658
Am J Gastroenterol. 2022 Jun 1;117(6):831-834
pubmed: 35333779
Gastroenterology. 2017 Jun;152(8):1954-1964
pubmed: 28283421
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1677-1678
pubmed: 29410051
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
Am J Gastroenterol. 2022 Feb 1;117(2):225-252
pubmed: 35006099
Gastroenterology. 2019 Apr;156(5):1368-1380.e10
pubmed: 30552895
J Hepatol. 2015 Apr;62(4):968-74
pubmed: 25638527
Ann Hepatol. 2020 Sep - Oct;19(5):523-529
pubmed: 32540327
Gastroenterology. 2010 Oct;139(4):1246-56, 1256.e1-5
pubmed: 20558165
Hepatology. 2014 Jul;60(1):250-6
pubmed: 24677131
Clin Gastroenterol Hepatol. 2015 Apr;13(4):753-9.e1-2
pubmed: 25130937
Hepatology. 2023 Jun 1;77(6):2030-2040
pubmed: 36645215
Ann Emerg Med. 2008 Sep;52(3):268-73
pubmed: 18433932
Am J Gastroenterol. 2019 Dec;114(12):1863-1869
pubmed: 31688022
Hepatology. 2021 Aug;74(2):1014-1048
pubmed: 33942342
N Engl J Med. 2021 Jun 17;384(24):2317-2330
pubmed: 34133861
Am J Gastroenterol. 2019 Jul;114(7):1091-1100
pubmed: 31180922
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1029-1036
pubmed: 28994123
J Hepatol. 2019 Mar;70(3):398-411
pubmed: 30391380
Hepatology. 2019 Dec;70(6):2062-2074
pubmed: 31107967
Hepatology. 2016 Apr;63(4):1299-309
pubmed: 26084406

Auteurs

Nilang Patel (N)

Division of Nephrology Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.

Scott Silvey (S)

Department of Biostatistics, Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.

Jacqueline G O'Leary (JG)

Dallas VA Medical Center, Dallas, Texas, USA.

Timothy Morgan (T)

Long Beach VA Medical Center, Long Beach, California, USA.

Heather Patton (H)

San Diego VA Medical Center, San Diego, California, USA.

Shari S Rogal (SS)

Pittsburgh VA Medical Center, Pittsburgh, Pennsylvania; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Jasmohan S Bajaj (JS)

Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH